LEADER 01340nam  2200433   450 
001 9910815317403321
005 20230814235029.0
010   $a3-527-80726-8
010   $a3-527-80724-1
010   $a3-527-80725-X
035   $a(CKB)4330000000010850
035   $a(MiAaPQ)EBC5472020
035   $a(EXLCZ)994330000000010850
100   $a20180820d2018      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aActive pharmaceutical ingredients in synthesis $ecatalytic processes in research and development /$fAnthony J. Burke [and three others]
210  1$aWeinheim, Germany :$cWiley-VCH Verlag GmbH & Co. KGaA,$d[2018]
210  4$dİ2018
215   $a1 online resource (453 pages)
311   $a3-527-34241-9 
606   $aPharmaceutical biotechnology
606   $aBioactive compounds$xSynthesis
606   $aCatalysis
615  0$aPharmaceutical biotechnology.
615  0$aBioactive compounds$xSynthesis.
615  0$aCatalysis.
676   $a338.476151
700   $aBurke$b Anthony J.$01651337
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910815317403321
996   $aActive pharmaceutical ingredients in synthesis$94001219
997   $aUNINA